INDICATION\

MACHANISM OF
DRUG NAME CONTRAINDICATION ADVERSE EFFECTS NURSING RESPONSIBILITY
ACTION
GENERIC NAME: Parenteral dextrose INDICATION -Frequency Not Defined -Suspend container from eyelet support.
Dextrose is oxidized to carbon Dextrose and Sodium Chl -Hyperosmolarity -Remove plastic protector from outlet port at bottom of
dioxide and water, oride Injection, USP is -Edema container.
BRAND Name: and provides 3.4 indicated as a source of -Venous thrombosis -Attach administration set. Refer to complete directions
D50W, DGlucose water, electrolytes, and
cal/g of d-glucose -Tachypnea accompanying set
calories. -Fever -Clinical evaluation and periodic laboratory determinations
Classifiation:
Glucose-Elevating -Hypermolar syndrome are necessary to monitor changes in fluid balance, electrolyte
CONTRAINDICATION -Hypervolemia concentrations, and acid base balance during prolonged
Agents;
Metabolic & Endocrine Solutions -Phlebitis parenteral therapy or whenever the condition of the patient
containing dextrose may -Diarrhea warrants such evaluation.
DOSEG be contraindicated in -Polydipsia -Lactated Ringer’s and 5% Dextrose Injection, USP should be
patients with -Pulmonary edema used with.
ROUTE: known allergy to corn or -Cerebral hemorrhage -caution. Excess administration may result in metabolic
IV Fluid corn products. -Mental confusion, alkalosis.
-unconsciousness Caution must be exercised in the administration of parenteral
-Cerebral ischemia fluids, especially those containing sodium ions to patients
-Hypophosphatemia receiving corticosteroids or corticotrophin.
-Hypomagnesemia -Solution containing acetate should be used with caution as
-Hyperglycemia excess administration may result in metabolic alkalosis.
-Injection site -If an adverse reaction does occur, discontinue the infusion,
-extravasation evaluate the patient, institute appropriate the rapeutic
-Tissue necrosis countermeasures